These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 39327253

  • 1. METTL3 Regulates the Translation of Oncogene Myc through m6A Modification and Promotes the Occurrence and Development of Cervical Cancer.
    Ma Y, Shi H, Zheng W.
    Discov Med; 2024 Sep; 36(188):1902-1910. PubMed ID: 39327253
    [Abstract] [Full Text] [Related]

  • 2. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C, Ren Q, Deng J, Wang S, Ren L.
    Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794
    [Abstract] [Full Text] [Related]

  • 3. [METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].
    Hu C, Liu T, Xu Y, Han C, Yang S, Yang K.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Feb; 38(2):131-137. PubMed ID: 35356881
    [Abstract] [Full Text] [Related]

  • 4. METTL3 facilitates the progression of cervical cancer by m6A modification-mediated up-regulation of NEK2.
    Guo Y, Bai Y, Wang L, Xu Z, Zhang N, Wang W, Zhao H.
    Sci Rep; 2024 Oct 18; 14(1):24469. PubMed ID: 39424828
    [Abstract] [Full Text] [Related]

  • 5. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
    Guo S, Chen F, Li L, Dou S, Li Q, Huang Y, Li Z, Liu W, Zhang G.
    J Adv Res; 2024 Jul 18; 61():165-178. PubMed ID: 37619934
    [Abstract] [Full Text] [Related]

  • 6. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Hou PX, Fan Q, Zhang Q, Liu JJ, Wu Q.
    Clin Exp Pharmacol Physiol; 2024 Jul 18; 51(7):e13868. PubMed ID: 38745265
    [Abstract] [Full Text] [Related]

  • 7. The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network.
    Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, Yuan Q, Li Y.
    Oncogene; 2019 May 18; 38(19):3667-3680. PubMed ID: 30659266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. METTL3's role in cervical cancer development through m6A modification.
    Liu Y, Li C, Deng Q, Ren X, Wang H.
    FASEB J; 2024 Jun 15; 38(11):e23693. PubMed ID: 38809685
    [Abstract] [Full Text] [Related]

  • 11. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M, Zhai X, Chen Y, Yin D.
    Pathol Res Pract; 2024 Aug 15; 260():155437. PubMed ID: 38959625
    [Abstract] [Full Text] [Related]

  • 12. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
    Wang XS, He JR, Yu S, Yu J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun 28; 40(3):308-314. PubMed ID: 29978784
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T, Yang S, Sui J, Xu SY, Cheng YP, Shen B, Zhang Y, Zhang XM, Yin LH, Pu YP, Liang GY.
    J Cell Physiol; 2020 Jan 28; 235(1):548-562. PubMed ID: 31232471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, Zhang TC, Liao XH.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742899
    [Abstract] [Full Text] [Related]

  • 20. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ, Cong CH, Li XJ, Zhu F, Zhao X, Chen FW.
    Eur Rev Med Pharmacol Sci; 2020 Apr 09; 24(8):4328-4336. PubMed ID: 32373970
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.